Neural transplantation in the treatment of patients with Parkinson's Disease

  • Barker, Roger (PI)
  • Björklund, Anders (PI)
  • Lindvall, Olle (Researcher)
  • Parmar, Malin (Researcher)
  • Grealish, Shane (Researcher)
  • Dunnett, Steve (PI)
  • Piccini, Paola (PI)
  • Foltynie, Thomas (PI)
  • Widner, Håkan (PI)
  • Bjartmarz, Hjalmar (Researcher)
  • Paul-Visse, Gesine (Researcher)

Project: Research

Project Details

Description

TRANSEURO is a European research consortium with the principal objective to develop an efficacious and safe treatment methodology for Parkinson’s disease suffering patients using fetal cell based treatments. The consortium has gathered international experts including leading clinicians, scientists, industrial partners, ethicists and patients’ representatives who have joined forces in a new round of experimental work and cell therapy trials in Parkinson's Disease.
TRANSEURO is coordinated by Prof. Roger Barker from the Cambridge University and is funded by the 7th Framework Program of the European Commission, Contract number HEALTH-F5-2010-242003.
Short titleTRANSEURO
AcronymTRANSEURO
StatusFinished
Effective start/end date2010/01/01 → 2016/06/30

Collaborative partners

  • Lund University
  • University of Cambridge (lead)
  • Albert-Ludwigs University Freiburg
  • Cardiff University
  • Imperial College London
  • University College London
  • Skåne University Hospital
  • Life Science Governance Institute
  • Henri Mondor Hospital
  • The European Clinical Research Infrastructures Network (ECRIN)
  • Inomed Medizintechnik GmbH
  • Life Technologies Ltd
  • Cambridge Cognition
  • Imanova Ltd

Funding

  • European Commission - FP7

UKÄ subject classification

  • Medical and Health Sciences

Free keywords

  • Parkinson's disease

Access Project